Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
22.22
-0.20 (-0.89%)
At close: Jul 30, 2025, 2:57 PM CST

Accolade Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
Operating Revenue
129.44125.76110.4283.440.4746.37
Upgrade
Other Revenue
3.713.713.831.340.030.25
Upgrade
133.15129.47114.2584.7440.546.62
Upgrade
Revenue Growth (YoY)
4.86%13.33%34.82%109.22%-13.13%123.50%
Upgrade
Cost of Revenue
97.7795.6381.1369.3549.7142.5
Upgrade
Gross Profit
35.3833.8433.1215.39-9.214.12
Upgrade
Selling, General & Admin
174.99171.16159.52135.04136.81109.4
Upgrade
Research & Development
119.94137.21214.23274.33172.11138.49
Upgrade
Other Operating Expenses
6.964.63.172.981.981.48
Upgrade
Operating Expenses
300.44310.75377.34413.94312.12249.77
Upgrade
Operating Income
-265.06-276.9-344.22-398.56-321.33-245.65
Upgrade
Interest Expense
-10.65-10.36-8.47-4.75-1.53-1.36
Upgrade
Interest & Investment Income
86.9788.2123.5125.944.37.37
Upgrade
Currency Exchange Gain (Loss)
0.150.15-3.580.680.09-0.62
Upgrade
Other Non Operating Income (Expenses)
-3.97-3.05-0.91-2.03-0.48-0.55
Upgrade
EBT Excluding Unusual Items
-192.56-201.95-333.66-378.75-278.96-240.81
Upgrade
Gain (Loss) on Sale of Investments
-1.320.08-1.06-0.250.721.27
Upgrade
Gain (Loss) on Sale of Assets
-0.02-0.03-3.08-0.010-0
Upgrade
Asset Writedown
-36.3-36.65-3.22---
Upgrade
Other Unusual Items
40.437.1612.0522.2512.974.02
Upgrade
Pretax Income
-189.8-201.38-328.96-356.76-265.27-235.52
Upgrade
Earnings From Continuing Operations
-189.8-201.38-328.96-356.76-265.27-235.52
Upgrade
Minority Interest in Earnings
----5.214.79
Upgrade
Net Income
-189.8-201.38-328.96-356.76-260.06-230.73
Upgrade
Net Income to Common
-189.8-201.38-328.96-356.76-260.06-230.73
Upgrade
Shares Outstanding (Basic)
372373374364361288
Upgrade
Shares Outstanding (Diluted)
372373374364361288
Upgrade
Shares Change (YoY)
-0.01%-0.24%2.69%0.79%25.23%9.40%
Upgrade
EPS (Basic)
-0.51-0.54-0.88-0.98-0.72-0.80
Upgrade
EPS (Diluted)
-0.51-0.54-0.88-0.98-0.72-0.80
Upgrade
Free Cash Flow
-203.48-191.12-396.52-429.42-570.22-356.59
Upgrade
Free Cash Flow Per Share
-0.55-0.51-1.06-1.18-1.58-1.24
Upgrade
Gross Margin
26.57%26.14%28.99%18.16%-22.74%8.85%
Upgrade
Operating Margin
-199.06%-213.87%-301.28%-470.32%-793.34%-526.88%
Upgrade
Profit Margin
-142.54%-155.54%-287.94%-421.01%-642.07%-494.89%
Upgrade
Free Cash Flow Margin
-152.82%-147.61%-347.07%-506.74%-1407.84%-764.83%
Upgrade
EBITDA
-249.99-256.28-301.34-352.29-283.37-207.46
Upgrade
EBITDA Margin
-187.75%-197.94%-263.76%---
Upgrade
D&A For EBITDA
15.0720.6342.8846.2737.9638.19
Upgrade
EBIT
-265.06-276.9-344.22-398.56-321.33-245.65
Upgrade
EBIT Margin
-199.06%-213.87%----
Upgrade
Revenue as Reported
133.15129.47114.2584.7440.546.62
Upgrade
Advertising Expenses
-0.520.310.091.130.81
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.